Glenmark Pharmaceuticals Ltd (GLENMARK) — Voting Results | 11 September 2026

· BSE 🟡 Notable Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
48th AGM approved FY2025-26 financials, declared Rs. 2.50 dividend, reappointed director, and ratified auditor remuneration
🔄 What Changed
Approved audited standalone and consolidated financial statements for FY2025-26
🔮 What's Next
None
💡 Investor Takeaway
Shareholders approved key financials and governance matters with strong majority support, signaling confidence in the company's direction.

Glenmark Pharmaceuticals held its 48th AGM on September 11, 2026 via video conference, approving audited standalone and consolidated financial statements for FY2025-26, declaring a dividend of Rs. 2.50 per share, reappointing Mrs. Blanche Saldanha as a Non-Executive Director, and ratifying the Cost Auditor's remuneration for FY2026-27. Shareholders cast votes electronically through NSDL, with results showing overwhelming approval across all resolutions. The meeting concluded at 3:51 p.m. after a 30-minute post-AGM e-voting window.

📄 View Original Announcement (PDF)

About Glenmark Pharmaceuticals Ltd (GLENMARK)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹68,205.11 Cr P/E: 37.9 ROE: 20.3% ROCE: 24.8% Div Yield: 0.10%

View full GLENMARK stock details →

📡 Get AI alerts when GLENMARK files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track GLENMARK — Free

📊 More GLENMARK filings

See all GLENMARK filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when GLENMARK files new disclosures

Track GLENMARK filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track GLENMARK — Free

Free account · 2 AI queries/day